<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02433756</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT02433756</nct_id>
  </id_info>
  <brief_title>RESponders and QUadripolar LV Lead in CRT</brief_title>
  <acronym>ResQ CRT</acronym>
  <official_title>Responders and Quadripolar LV Lead in CRT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Santa Croce-Carle Cuneo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Santa Croce-Carle Cuneo</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the evolution of the CRTD system with left
      quadripolar lead, in terms of electrical parameters in all pacing configurations and to
      evaluate the impact on the clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac resynchronization therapy (CRT) is limited by a high proportion of non-responders.

      Pacing activation from proximal area with a left quadripolar lead might improve the
      depolarization pattern.

      To explore the effect of CRT pacing on cardiac activity, the investigators will enroll
      approximately 180 patients who already underwent CRT-D implantation with a quadripolar LV
      lead.

      After implant, as clinical practice, the device will be programmed with distal LV pacing
      configuration, after 6 months in patient non-responders to CRT therapy the pacing
      configuration will be changed (proximal configuration).

      After 12 months in patients non-responders will be changed the pacing configuration again,
      choosing, if it is possible, a multi point pacing (pacing activation from multiple separated
      left ventricular (LV) sites).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Percentage of patients presenting improving in Heart Failure Clinical Composite and reverse remodeling after 6 months</measure>
    <time_frame>6-Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients presenting improving in Heart Failure Clinical Composite and reverse remodeling after 12 months</measure>
    <time_frame>12-Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients presenting improving in Heart Failure Clinical Composite and reverse remodeling after 18 months</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRTD</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be in NYHA II, III or IV functional class with approved standard indication by
             ESC/EHRA Guidelines

          -  Successful quadripolar LV lead implant

        Exclusion Criteria:

          -  Less than 18 years of age

          -  Epicardial Lead

          -  Life expectancy &lt; 12 months

          -  Pregnant or are planning to become pregnant during the duration of the investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ciriè Hospital</name>
      <address>
        <city>Ciriè</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaetano Senatore</last_name>
      <email>resqcrt@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.Croce e Carle Hospital</name>
      <address>
        <city>Cuneo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonello Vado</last_name>
      <email>resqcrt@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maria Vittoria Hospital</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Giammaria</last_name>
      <email>resqcrt@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2015</study_first_submitted>
  <study_first_submitted_qc>April 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2015</study_first_posted>
  <last_update_submitted>March 29, 2016</last_update_submitted>
  <last_update_submitted_qc>March 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Santa Croce-Carle Cuneo</investigator_affiliation>
    <investigator_full_name>Antonello Vado</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

